| Device Classification Name |
Classifier, Prognostic, Recurrence Risk Assessment, Rna Gene Expression, Breast Cancer
|
| 510(k) Number |
K141142 |
| FOIA Releasable 510(k) |
K141142
|
| Device Name |
MAMMAPRINT FFPE |
| Applicant |
| AGENDIA |
| SCIENCE PARK 406 |
|
AMSTERDAM,
NL
1098XH
|
|
| Applicant Contact |
Guido Brink |
| Correspondent |
| AGENDIA |
| SCIENCE PARK 406 |
|
AMSTERDAM,
NL
1098XH
|
|
| Correspondent Contact |
Guido Brink |
| Regulation Number | 866.6040 |
| Classification Product Code |
|
| Date Received | 05/02/2014 |
| Decision Date | 01/23/2015 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Immunology
|
| 510k Review Panel |
Pathology
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Traditional
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|